# Radica Z. Alicic

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/radica-z-alicic/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,044 |
| Field | Diabetes Treatment and Management |
| h-index | 36 |
| i10-index | 60 |
| Last Known Institution | Providence Regional Medical Center Everett |
| OpenAlex ID | https://openalex.org/A5005596615 |
| ORCID iD | 0000-0002-5437-5700 |
| Works | 139 |

## Researcher papers

- [Diabetic Kidney Disease](https://scholariq.org/papers/diabetic-kidney-disease-2/)
- [Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection](https://scholariq.org/papers/development-of-a-definition-of-postacute-sequelae-of-sars-cov-2-infection/)
- [The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/the-case-for-early-identification-and-intervention-of-chronic-kidney-disease/)
- [Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children](https://scholariq.org/papers/clinical-characteristics-of-and-risk-factors-for-chronic-kidney-disease-among/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence](https://scholariq.org/papers/incretin-drugs-in-diabetic-kidney-disease-biological-mechanisms-and-clinical/)
- [Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease](https://scholariq.org/papers/inflammatory-mechanisms-as-new-biomarkers-and-therapeutic-targets-for-diabetic/)
- [Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium](https://scholariq.org/papers/albuminuria-testing-in-hypertension-and-diabetes-an-individual-participant-data/)
- [SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review](https://scholariq.org/papers/sglt2-inhibition-for-the-prevention-and-treatment-of-diabetic-kidney-disease-a/)
- [Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial](https://scholariq.org/papers/baricitinib-versus-dexamethasone-for-adults-hospitalised-with-covid-19-actt-4-a/)
- [Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry](https://scholariq.org/papers/population-level-risk-factors-for-kidney-outcomes-in-iga-nephropathy-the-cure/)
- [Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry](https://scholariq.org/papers/population-risk-predictors-of-major-adverse-kidney-events-attributed-to-focal/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [Providence Regional Medical Center Everett](https://scholariq.org/institutions/providence-regional-medical-center-everett/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.